Skip to main content
. 2019 Jun 28;14(6):e0219013. doi: 10.1371/journal.pone.0219013

Table 1. Clinical characteristics of patients who were enrolled in this study.

Characteristics RNA-Seq Discovery Cohort All enrolled patients
Control (n = 10) AAAD (n = 10) P Control (n = 30) AAAD (n = 30) P
Age (years) 60.9±3.0 59.3±3.9 0.75 56.1±15.3 56.7±12.3 0.87
Male (%) 4 (40%) 5 (50%) 1.00 14 (47%) 19 (63%) 0.19
Height (cm) 163±2.4 168±1.5 0.07 164.8±7.0 168.1±6.7 0.06
Weight (kg) 63.3±3.0 71.3±4.5 0.16 66.6±8.6 69.6±13.0 0.24
BMI (kg/m2) 23.7±0.8 25.0±1.4 0.45 24.4±2.64 24.5±3.6 0.93
Hypertension (n) 3(30%) 7(70%) 0.18 20 (67%) 24(80%) 0.38
Diabetes mellitus (n) 0(0%) 1(10%) 1.00 4 (13.3%) 1(3.3%) 0.35
Smoking history (n) 0(0%) 0(0%) 1.00 0 (0%) 1 (3.3%) 1.00
Alcoholism (n) 0(0%) 0(0%) 1.00 6 (20%) 5 (16.7%) 1.00
CKD (n) 0(0%) 0(0%) 1.00 3 (10%) 2 (6.7%) 1.00
Stroke (n) 0(0%) 0(0%) 1.00 0 (0%) 1 (3.3%) 1.00

The P value refers to comparisons between the AAAD and the control group. The data are presented as the mean ± SD. BMI, body mass index; CKD, chronic kidney disease; AAAD, acute Stanford type A aortic dissection.